Constitutive Interferon Pathway Activation in Tumors as an Efficacy Determinant Following Oncolytic Virotherapy
JNCI: Journal of the National Cancer Institute | March 6, 2018 | Volume: 110 | Issue: 10 | Pages: 1123-1132
10.1093/jnci/djy033
| PMID 29788332